Javier Bardem Talks Genocide, A Hollywood Blacklist & The Tide Turning Politically: “Those Who Are Drawing Up The So-Called Blacklist Will Actually Be Exposed, And They Are The Ones Who Will Be Suffering”
Javier Bardem discussed his new film 'The Beloved,' shot in Western Sahara, during a press event at Cannes, where he addressed political controversies surrounding his views on the Israel-Palestine conflict. He expressed readiness to face consequences for his stance, emphasizing personal integrity and the importance of speaking out against genocide. Bardem believes public opinion in Hollywood and beyond is shifting, with those supporting silence or justification of atrocities ultimately facing social repercussions.
- ▪Javier Bardem spoke at Cannes about his film 'The Beloved,' which was shot in the politically sensitive region of Western Sahara.
- ▪He stated that genocide in Gaza is a fact and that silence or support equates to being complicit in it.
- ▪Bardem believes those creating a so-called Hollywood blacklist will be exposed and suffer social consequences as public awareness grows.
- ▪He credited younger generations for increasing awareness of global issues through digital media.
- ▪Despite potential backlash, Bardem affirmed he has no 'B plan' and is prepared to accept any consequences for his position.
Opening excerpt (first ~120 words) tap to expand
Javier Bardem at the El Ser Querido' (The Beloved)' photocall in Cannes Andreas Rentz/Getty Images “There is no B plan, no alternative, and this entails consequences, which I’m fully ready to shoulder.” That’s Javier Bardem, in Cannes discussing his new film The Beloved, which was shot in the Western Sahara. Given the politics of that region and the controversy over Bardem’s recent statements about the conflict between Israel and the Palestinians, he was inevitably asked about whether he feared a backlash to his position, and whether the mood about those topics might be changing in Hollywood.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Deadline.
Discussion
0 commentsMore from Deadline
